98 related articles for article (PubMed ID: 33968180)
1. Ocular Manifestation in Systemic Sclerosis-A Literature Review.
Paczwa K; Rerych M; Romanowska-Próchnicka K; Różycki R; Gołębiewska J
Life (Basel); 2024 May; 14(5):. PubMed ID: 38792647
[TBL] [Abstract][Full Text] [Related]
2. The Role of Trace Elements in Pseudoexfoliation Syndrome: A Cross-sectional Study.
Talebnejad MR; Azimi A; Khalili MR; Meshksar A
J Ophthalmic Vis Res; 2021; 16(2):165-170. PubMed ID: 34055253
[TBL] [Abstract][Full Text] [Related]
3. Pseudoexfoliation Syndrome-Clinical Characteristics of Most Common Cause of Secondary Glaucoma.
Tomczyk-Socha M; Tomczak W; Winkler-Lach W; Turno-Kręcicka A
J Clin Med; 2023 May; 12(10):. PubMed ID: 37240686
[TBL] [Abstract][Full Text] [Related]
4. Pseudoexfoliation syndrome: pathological manifestations of relevance to intraocular surgery.
Conway RM; Schlötzer-Schrehardt U; Küchle M; Naumann GO
Clin Exp Ophthalmol; 2004 Apr; 32(2):199-210. PubMed ID: 15068440
[TBL] [Abstract][Full Text] [Related]
5. [Pseudoexfoliation syndrome (PEX)--a systemic disorder].
Kurowska AK; Kamińska A; Izdebska J; Szaflik JP; Szaflik J
Klin Oczna; 2009; 111(4-6):160-4. PubMed ID: 19673450
[TBL] [Abstract][Full Text] [Related]
6. Changes in peri-ocular anatomy and physiology in pseudoexfoliation syndrome (Review).
Detorakis ET; Bontzos G; Drakonaki EE; Spandidos DA
Exp Ther Med; 2021 Jun; 21(6):650. PubMed ID: 33968180
[TBL] [Abstract][Full Text] [Related]
7. Novel protein constituents of pathological ocular pseudoexfoliation syndrome deposits identified with mass spectrometry.
Sharma S; Chataway T; Klebe S; Griggs K; Martin S; Chegeni N; Dave A; Zhou T; Ronci M; Voelcker NH; Mills RA; Craig JE
Mol Vis; 2018; 24():801-817. PubMed ID: 30713420
[TBL] [Abstract][Full Text] [Related]
8. Cataract Surgery and Possible Complications in Patients with Pseudoexfoliation Syndrome.
Erkayhan GE; Dogan S
Eurasian J Med; 2017 Feb; 49(1):22-25. PubMed ID: 28416927
[TBL] [Abstract][Full Text] [Related]
9. [Pseudoexfoliation syndrome and phacoemulsification: comparative study with a control population].
Sarda V; Rohart C; Fajnkuchen F; Nghiem Buffet S; Streho M; Chaine G
J Fr Ophtalmol; 2010 May; 33(5):319-26. PubMed ID: 20452095
[TBL] [Abstract][Full Text] [Related]
10. [Pseudoexfoliation Syndrome and Glaucoma].
Nobl M; Mackert M
Klin Monbl Augenheilkd; 2019 Sep; 236(9):1139-1155. PubMed ID: 31412384
[TBL] [Abstract][Full Text] [Related]
11. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
[TBL] [Abstract][Full Text] [Related]
12. Association between Obstructive Sleep Apnea and Exfoliation Syndrome: The Utah Project on Exfoliation Syndrome.
Shumway C; Curtin K; Taylor S; Sundar KM; Wirostko BM; Ritch R
Ophthalmol Glaucoma; 2021; 4(3):260-267. PubMed ID: 33007491
[TBL] [Abstract][Full Text] [Related]
13. Tear film abnormalities in pseudoexfoliation syndrome and normal healthy participants: A comparative analysis.
Noori S; Sati A; Moulick PS; Kaushik J; Shankar S; Bose R
Med J Armed Forces India; 2020 Jul; 76(3):303-306. PubMed ID: 32773933
[TBL] [Abstract][Full Text] [Related]
14. Association between Chronic Obstructive Pulmonary Disease and Exfoliation Syndrome: The Utah Project on Exfoliation Syndrome.
Taylor SC; Bernhisel AA; Curtin K; Allingham RR; Ritch R; Wirostko BM
Ophthalmol Glaucoma; 2019; 2(1):3-10. PubMed ID: 32672555
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
